| Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. RJ Pickering, C Tikellis, CJ Rosado, D Tsorotes, A Dimitropoulos, M Smith, ... The Journal of clinical investigation, 2018 | 76 | 2018 |
| Mutations of vasopressin receptor 2 including novel L312S have differential effects on trafficking A Tiulpakov, CW White, RS Abhayawardana, HB See, AS Chan, ... Molecular Endocrinology 30 (8), 889-904, 2016 | 48 | 2016 |
| Receptor activity-modifying proteins 2 and 3 generate adrenomedullin receptor subtypes with distinct molecular properties HA Watkins, M Chakravarthy, RS Abhayawardana, JJ Gingell, M Garelja, ... Journal of Biological Chemistry, jbc. M115. 688218, 2016 | 47 | 2016 |
| Investigation of Receptor Heteromers Using NanoBRET Ligand Binding EKM Johnstone, HB See, RS Abhayawardana, A Song, KJ Rosengren, ... International Journal of Molecular Sciences 22 (3), 1082, 2021 | 10 | 2021 |
| Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partners EKM Johnstone, RS Abhayawardana, HB See, RM Seeber, SL O'Brien, ... Biochemical Pharmacology 188, 114521, 2021 | 2 | 2021 |
| CXCL17 is an endogenous inhibitor of CXCR4 via a novel mechanism of action CW White, LE Kilpatrick, N Dale, RS Abhayawardana, S Dekkers, ... bioRxiv, 2021 | 2 | 2021 |
| Detection and characterisation of GPCR heteromers using NanoBRET ligand binding EK Johnstone, HB See, RS Abhayawardana, A Song, KJ Rosengren, ... British Journal of Pharmacology 176 (16), 3046-3046, 2019 | | 2019 |
| Profiling of a Novel NSIAD-Causing Mutation of Vasopressin Receptor 2 and its Differential Effect on Receptor Trafficking Compared to Previously Identified Mutations A Tiulpakov, CW White, R Abhayawardana, N Zubkova, RM Seeber, ... 54th Annual ESPE 84, 2015 | | 2015 |
Professor Kevin PflegerThe University of Western Australia and Harry Perkins Institute of Medical ResearchVerified email at uwa.edu.au
